1-3 of 3
Keywords: nitroglycerine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Impact of age on the vasovagal response provoked by sublingual nitroglycerine in routine tilt testing

Bart Verheyden, Janneke Gisolf, Frank Beckers, John M. Karemaker, Karel H. Wesseling, André E. Aubert, Wouter Wieling
Journal: Clinical Science
Clin Sci (Lond) (2007) 113 (7): 329–337.
DOI: https://doi.org/10.1042/CS20070042
Published: 03 September 2007
...Bart Verheyden; Janneke Gisolf; Frank Beckers; John M. Karemaker; Karel H. Wesseling; André E. Aubert; Wouter Wieling NTG (nitroglycerine) is used in routine tilt testing to elicit a vasovagal response. In the present study we hypothesized that with increasing age NTG triggers a more gradual BP...
View article titled, Impact of age on the vasovagal response provoked by sublingual <span class="search-highlight">nitroglycerine</span> in routine tilt testing
Open the PDF for Impact of age on the vasovagal response provoked by sublingual <span class="search-highlight">nitroglycerine</span> in routine tilt testing in another window
Articles

Side-effects of L-dopa on venous tone in Parkinson's disease: a leg-weighing assessment

Jean-Pierre Wolf, Malika Bouhaddi, Francis Louisy, Andrei Mikehiev, Laurent Mourot, Sylvie Cappelle, Fabrice Vuillier, Pierre Andre, Lucien Rumbach, Jacques Regnard
Journal: Clinical Science
Clin Sci (Lond) (2006) 110 (3): 369–377.
DOI: https://doi.org/10.1042/CS20050247
Published: 10 February 2006
.... The reproducibility of leg weighing technique was assessed by performing the measurements with TC pressures at 30 and 50 mmHg three times 1 h apart in the eight healthy subjects. 5 8 2005 11 11 2005 22 11 2005 22 11 2005 The Biochemical Society 2006 nitroglycerine noradrenaline...
View article titled, Side-effects of L-dopa on venous tone in Parkinson's disease: a leg-weighing assessment
Open the PDF for Side-effects of L-dopa on venous tone in Parkinson's disease: a leg-weighing assessment in another window
Articles

Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes

Craig CHEETHAM, Gerard O'DRISCOLL, Kim STANTON, Roger TAYLOR, Daniel GREEN
Journal: Clinical Science
Clin Sci (Lond) (2001) 100 (1): 13–17.
DOI: https://doi.org/10.1042/cs1000013
Published: 05 December 2000
... Green (e-mail brevis@cyllene.uwa.edu.au ). 4 5 2000 13 7 2000 7 9 2000 The Biochemical Society and the Medical Research Society © 2001 2001 angiotensin receptor blockade diabetes mellitus endothelium flow-mediated dilation nitric oxide nitroglycerine 13Clinical...
View article titled, Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes
Open the PDF for Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes in another window